One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1200/jco.2014.32.15_suppl.e17015
Copy DOI Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2014 |
Affiliation: Vall d'Hebron Hospital Universitari, Hospital Universitario Miguel Servet, Hospital Clínic de Barcelona, Parc Taulí Hospital Universitari, Autonomous University of Barcelona, Hospital Universitari Germans Trias i Pujol, Institut Català d'Oncologia, Hospital Universitario de Valme, Hospital Universitario La Paz, Hospital Universitario Ramón y Cajal, Hospital General De Segoviae17015 Background: Vandetanib is a multikinase inhibitor (MKI) directed against VEGFR2-3, RET, RET/PTC and EGFR that has demonstrated significant efficacy in advanced MTC in a large phase III trial...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
